Patients with malignant tumors can generally eat mushrooms, but it should be consumed in moderation according to individual circumstances. Mushrooms are rich in polysaccharides and trace elements, which can help enhance immunity, but some patients may have weakened gastrointestinal function or need to adjust their diet during special treatment stages. Mushrooms contain active ingredients such as shiitake polysaccharides and selenium, which can assist in regulating immune function and have certain benefits for patients after radiotherapy and chemotherapy. Common mushrooms such as Pleurotus ostreatus and Flammulina velutipes have proteins that are easily absorbed, making them suitable for supplementing nutrition during the postoperative recovery period. When cooking, it is recommended to choose steaming, boiling soup, and other methods to avoid deep frying or spicy seasoning. Some wild mushrooms may contain toxins, so it is recommended to purchase artificially cultivated varieties through legitimate channels. Patients undergoing targeted therapy or immunotherapy who experience severe symptoms such as diarrhea and oral ulcers should temporarily reduce their intake of mushrooms. Patients with bone marrow suppression should ensure that mushrooms are fully heated and sterilized, and avoid consuming cold mixed products. Patients with combined hyperuricemia should control their food intake, with a recommended daily limit of no more than 100 grams.
The diet of patients with malignant tumors should follow the principle of individualization, and mushrooms can be included as part of the dietary mix. It is recommended to develop a diet under the guidance of a nutritionist and regularly monitor nutritional indicators during treatment. If discomfort such as bloating and rash occurs after consumption, it is necessary to pause and consult a doctor in a timely manner. Maintaining food diversity, combined with appropriate amounts of high-quality protein and fresh vegetables and fruits, is more conducive to recovery.
Comments (0)
Leave a Comment
No comments yet
Be the first to share your thoughts!